Position in QGEN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$312
-$8 QoQ
Shares Held
8
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#324
of 332 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Stone House Investment Management, LLC holds $24,604 across 11 Diagnostics & Research names. QGEN ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
59 | $11,238 | |
| 2 | MYGN |
Myriad Genetics Inc
|
1,000 | $5,710 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
10 | $5,013 | |
| 4 | TWST |
Twist Bioscience Corp
|
9 | $925 | |
| 5 | CDNA |
CareDx, Inc.
|
17 | $484 | |
| 6 | WAT |
Waters Corp /De/
|
1 | $375 | |
| 7 | QGEN |
Qiagen N.V.
This page
|
8 | $312 | |
| 8 | A |
Agilent Technologies, Inc.
|
2 | $265 |
All Filings in QGEN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $312 | 8 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $320 | 8 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $404 | 9 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $759 | 17 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||